Cardiex Ltd
ASX:CDX
Cardiex Ltd
ASX:CDX
Price:
0.063 AUD
-11.27%
Market Closed
Updated:
Apr 24, 2024
Cardiex Ltd
Revenue
Last
Value
3-Years CAGR
5-Years CAGR
|
Cardiex Ltd
Revenue Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
EMV
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Cardiex Ltd
ASX:CDX
|
Revenue
AU$12.9m
|
CAGR 3-Years
37%
|
CAGR 5-Years
26%
|
CAGR 10-Years
7%
|
|
|
Neurotech International Ltd
ASX:NTI
|
Revenue
AU$1.3m
|
CAGR 3-Years
148%
|
CAGR 5-Years
83%
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Revenue
AU$10.5m
|
CAGR 3-Years
17%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
9%
|
|
|
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$7.1m
|
CAGR 3-Years
93%
|
CAGR 5-Years
70%
|
CAGR 10-Years
N/A
|
See Also
What is Cardiex Ltd's Revenue?
Revenue
12.9m
AUD
12.9m
AUD
Based on the financial report for Dec 31, 2023, Cardiex Ltd's Revenue amounts to 12.9m AUD.
What is Cardiex Ltd's Revenue growth rate?
Revenue CAGR 10Y
7%
7%
Over the last year, the Revenue growth was 246%. The average annual Revenue growth rates for Cardiex Ltd have been 37% over the past three years , 26% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
